Regeneron Pharmaceuticals: The Eyleas Have It
May 05, 2016 at 10:09 AM EDT
Investors are cheering Regeneron Pharmaceuticals' ( REGN ) financial results today--despite the fact that its earnings came in light . Leerink's Geoffrey Porges explains why:
